Technical Analysis for SCNI - Scinai Immunotherapeutics Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| NR7 | Range Contraction | 4.16% | |
| Wide Bands | Range Expansion | 4.16% | |
| Gapped Down | Weakness | 4.16% | |
| Calm After Storm | Range Contraction | -3.35% | |
| Wide Bands | Range Expansion | -3.35% |
| Alert | Time |
|---|---|
| Up 3% | 2 days ago |
| Up 2% | 2 days ago |
| Up 1% | 2 days ago |
| Possible NR7 | 2 days ago |
| Possible Inside Day | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2023
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Contract Manufacturing Organization Autoimmune And Infectious Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Contract Manufacturing Organization Autoimmune And Infectious Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.7 |
| 52 Week Low | 1.0 |
| Average Volume | 5,065 |
| 200-Day Moving Average | 6.56 |
| 50-Day Moving Average | 4.54 |
| 20-Day Moving Average | 4.17 |
| 10-Day Moving Average | 3.85 |
| Average True Range | 0.40 |
| RSI (14) | 44.75 |
| ADX | 22.07 |
| +DI | 15.20 |
| -DI | 18.11 |
| Chandelier Exit (Long, 3 ATRs) | 3.54 |
| Chandelier Exit (Short, 3 ATRs) | 4.40 |
| Upper Bollinger Bands | 4.94 |
| Lower Bollinger Band | 3.40 |
| Percent B (%b) | 0.23 |
| BandWidth | 36.98 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.21 |
| MACD Histogram | -0.0368 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.87 | ||||
| Resistance 3 (R3) | 3.86 | 3.80 | 3.85 | ||
| Resistance 2 (R2) | 3.80 | 3.77 | 3.81 | 3.84 | |
| Resistance 1 (R1) | 3.78 | 3.75 | 3.79 | 3.79 | 3.84 |
| Pivot Point | 3.72 | 3.72 | 3.73 | 3.73 | 3.72 |
| Support 1 (S1) | 3.70 | 3.69 | 3.71 | 3.71 | 3.66 |
| Support 2 (S2) | 3.64 | 3.67 | 3.65 | 3.66 | |
| Support 3 (S3) | 3.62 | 3.64 | 3.65 | ||
| Support 4 (S4) | 3.63 |
